L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.322 GBX -0.72% Market Closed
Market Cap: 134.1m GBX
Have any thoughts about
Life Science REIT PLC?
Write Note
Section:
 

Relative Value

The Relative Value of one LABS stock under the Base Case scenario is 66.032 GBX. Compared to the current market price of 38.322 GBX, Life Science REIT PLC is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LABS Relative Value
Base Case
66.032 GBX
Undervaluation 42%
Relative Value
Price
L
Worst Case
Base Case
Best Case

Valuation Multiples

6.7
P/S
P/S
Price to Sales
6.7
vs History
7
vs Industry
33
Median 3Y
0
Median 5Y
0
Industry
3.6
Forward
8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
16.7
Forward
21.2
More Details
11.4
P/OCF
P/OCF
Price to OCF
11.4
vs History
15
vs Industry
23
Median 3Y
0
Median 5Y
0
Industry
10.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
50
Median 3Y
0
Median 5Y
0
Industry
13.3
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
52
vs Industry
71
Median 3Y
0.7
Median 5Y
0.7
Industry
0.8
More Details
12
EV/S
EV/S
Enterprise Value to Sales
12
vs History
5
vs Industry
30
Median 3Y
0
Median 5Y
0
Industry
6.6
Forward
14.4
More Details
16.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.7
vs History
5
vs Industry
33
Median 3Y
0
Median 5Y
0
Industry
11.9
More Details
25.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.6
vs History
7
vs Industry
19
Median 3Y
0
Median 5Y
0
Industry
15.8
Forward
21.2
More Details
25.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.6
vs History
7
vs Industry
28
Median 3Y
0
Median 5Y
0
Industry
19
Forward
21.8
More Details
20.5
EV/OCF
EV/OCF
Enterprise Value to OCF
20.5
vs History
15
vs Industry
21
Median 3Y
0
Median 5Y
0
Industry
18.5
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
20.1
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
31
vs Industry
61
Median 3Y
0.6
Median 5Y
0.6
Industry
0.7
More Details

Multiples Across Competitors

LABS Competitors Multiples
Life Science REIT PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Life Science REIT PLC
LSE:LABS
134.1m GBP 6.7 -3.3 25.6 25.6
US
Welltower Inc
NYSE:WELL
77B USD 10.3 84.1 32.8 78.6
US
Ventas Inc
NYSE:VTR
24.5B USD 5.1 -368.9 17.8 52.3
US
Physicians Realty Trust
NYSE:DOC
14B USD 5.5 45.4 14.4 38.2
US
Healthpeak Properties Inc
F:HC5
13.4B EUR 5.5 45.4 14.4 38.1
US
Omega Healthcare Investors Inc
NYSE:OHI
10.1B USD 10 29 16.4 24.7
US
Healthcare Realty Trust Inc
NYSE:HR
6.4B USD 4.8 -22.7 14.6 211.6
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 7.1 58.8 18.6 47.7
US
CareTrust REIT Inc
NYSE:CTRE
4.7B USD 17.2 46.9 20.5 26.9
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4B USD 5.9 41.3 15.5 26.3
US
National Health Investors Inc
NYSE:NHI
3B USD 9.2 23.6 16.3 22.4
P/E Multiple
Earnings Growth P/E to Growth
UK
L
Life Science REIT PLC
LSE:LABS
Average P/E: 46.8
Negative Multiple: -3.3 		N/A N/A
US
Welltower Inc
NYSE:WELL
84.1
309%
0.3
US
Ventas Inc
NYSE:VTR
Negative Multiple: -368.9 N/A N/A
US
Physicians Realty Trust
NYSE:DOC
45.4
-37%
N/A
US
H
Healthpeak Properties Inc
F:HC5
45.4
-37%
N/A
US
Omega Healthcare Investors Inc
NYSE:OHI
29
85%
0.3
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -22.7 N/A N/A
US
H
Healthcare Trust Of America Inc
F:HT01
58.8
N/A N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
46.9
417%
0.1
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
41.3
1 210%
0
US
National Health Investors Inc
NYSE:NHI
23.6
11%
2.1

See Also

Summary
LABS intrinsic value, competitors valuation, and company profile.
DCF Valuation
LABS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LABS stock valuation using valuation multiples.
Wall Street Estimates
LABS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LABS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.